Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: Possible influence of p53 but not human papillomavirus E6/E7

Cancer Research

Volumn 58, Issue 14, 1998, Pages 3142-3149

  Woods, Kendra V ^a   Adler Storthz, Karen ^a   Clayman, Gary L ^a   Francis, Gail M ^a   Grimm, Elizabeth A ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MUTANT PROTEIN; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN SECRETION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VIRAL PROTEINS;

EID: 0032527903     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. Cancer Statistics. CA Cancer J. Clin., 47: 5-27, 1997.
2. Talmadge, J. E., Wolman, S. R., and Fidler, I. F. Evidence for the clonal origin of spontaneous metastases. Science (Washington DC), 217: 361-363, 1982.
3. Cornil, I., Theodorescu, D., Man, S., Herlyn, M., Jambrosic, J., and Kerbel, R. S. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl. Acad. Sci. USA, 88: 6028-6032, 1991.
4. Lu, C., and Kerbel, R. S. Interleukin 6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol., 120: 1281-1288, 1993.
5. Balkwill, F. R. General principles of cytokine therapy in cancer. In: Cytokines in Cancer Therapy, pp. 1-53. Oxford, United Kingdom: Oxford University Press, 1989.
6. Woods, K. V., El-Naggar, A., Clayman, G. L., and Grimm, E. A. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res., 58: 3132-3141, 1998.
7. Francis, G. M., Krohn, E. G., Woods, K. V., Buzaid, A. C., and Grimm, E. A. Interleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1. Melanoma Res., 6: 1-11, 1996.
8. Dinerello, C. A. The IL-1 family: 10 years of discovery. FASEB J., 8: 1314-1325, 1994.
9. Balkwill, F. R. The other interleukins. In: Cytokines in Cancer Therapy, pp. 150-181. Oxford, United Kingdom: Oxford University Press, 1989.
10. Simms, J. E., Giri, J. G., and Dower, S. K. The two interleukin-1 receptors play different roles in IL-1 actions. Clin. Immunol. Immunopathol., 72: 9-14, 1994.
11. Leung, K., Betts, J. C., Xu, L., and Nalsc, G. J. The cytoplasmic domain of the interleukin-1 receptor is required for nuclear factor-KB signal transduction. J. Biol. Chem., 269: 1579-1582, 1994.
12. Hirano, T. Interleukin-6. In: A. Thomson (ed.), Cytokine Handbook, pp. 169-190. London: Academic Press, 1991.
13. Schantz, S. P., Savage, H. E., and Lee, N. K. Head and neck tumor immunology. In: C. Jacobs (ed.), Carcinomas of the Head and Neck: Evaluation and Management, pp. 245-263. Boston: Kluwer Academic Publishers, 1990.
14. Bradford, C. R., Hoffman, H. T., Wolf, G. T., Carey, T. E., Baker, S. R., and McClatchey, K. D. Squamous carcinoma of the head and neck in organ transplant recipients: possible role of oncogenic viruses. Laryngoscope, 100: 190-194, 1990.
15. Lookingbill, D. P., Kreider, J. W., Howett, M. K., Olmstead, P. M., and Conner, G. H. Human papillomavirus structural antigens in oral papillomas and leukoplakias, J. Oral Pathol. Med., 13: 55-65, 1987.
16. Woods, K. V., Shillitoe, E. J., Spitz, M. R., Schantz, S. P., and Adler-Storthz, K. Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J. Oral Pathol. Med., 22: 101-108, 1993.
17. Sacks, P. G., Hong, W. K., and Hittelman, W. N. In vitro studies of the premalignant process: initial culture of oral premalignant lesions. Cancer Bull., 43: 485-489, 1991.
18. Liu, T. J., Zhang, W-W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by introduction of a wild-type p53 gene via recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
19. Krause, C. J., Carey, T. E., Ott, R. W., Hurbis, C., McClatchey, K. D., and Regezi, J. A. Human squamous cell carcinoma: establishment and characterization of new permanent cell lines. Arch. Otolaryngol., 107: 703-710, 1981.
20. Park, N. H., Min, B-M., Li, S-I., Huang, M. Z., Cherick, H. M., and Doniger, J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis (Lond.), 12: 1627-1631, 1991.
21. Hermann, B. G., and Frischauf, A. M. Isolation of genomic DNA. Methods Enzymol., 152: 180-183, 1987.
22. Boshard, M., Gissman, L., Ikenberg, H., Kleinheinz, A., Scheurlen, W., and zur Hausen, H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J., 3: 1151-1157, 1984.
23. Schwarz, E., Freese, U. K., Gissman, L., Mayer, W., Roggenbuck, B., Stremlau, A., and zur Hausen, H. H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (Lond.), 314: 111-114, 1985.
24. Yee, C., Krishnan-Hewlett, I., Baker, C., Schlege, L. R., and Howley, P. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol., 119: 361-366, 1985.
25. Pater, M. M., and Pater, A. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology, 145: 313-318, 1985.
26. Manos, M. M., Ting, Y., Wright, D. K., Lewis, A. J., Broker, T. R., and Wolinsky, S. M. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells, 7: 209-213, 1989.
27. Broker, T. R. Structure and genetic expression of papillomaviruses. Obstet. Gynecol. Clin. North Am, 14: 328-348, 1987.
28. Brenner, C. A., Tam, A. W., Nelson, P. A., Engleman, E. G., Suzuki, N., Fry, K. E., and Larrick, J. W. Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. BioTechniques, 7: 1096-1103, 1989.
29. Werness, B. A., Munger, K., Howley, P. M. Role of human papillomavirus oncoproteins in transformation and carcinogenic progression. Imp. Adv. Oncol., pp. 3-18. 1991.
30. Xu, L., Davidson, B. J., Murty, V. V., Rong-Guo, L., Sacks, P. G., Garin-Chesa, P., Schantz, S., and Chaganti, R. S. K. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int. J. Cancer, 59: 383-387, 1994.
31. Kim, M. S., Shin, K-H., Baek, J-H., Cherrick, H. M., and Park, N-H. HPV-16, tobacco-specific N-nitrosoamine, and N-methyl-N′-nitro-N-nitrosoguanidine in oral carcinogenesis. Cancer Res., 53: 4811-4816, 1993.
32. Beauchemin, V., Villeneuva, L., Rodriguez-Cimadevilla, J. C., Rajotte, D., Kenney, J. S., Clark, S. C., and Hoang, T. Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications. J. Cell Physiol., 148: 353-361, 1991.
33. Suzuki, A., Takahashi, T., Okuno, Y., Tsuyuoka, R., Fugimoto, M., Nakamura, K., and Imura, H. IL-1 production as a regulator of G-CSF and IL-6 production in CSF-producing cell lines. Br. J. Cancer, 565: 515-518, 1991.
34. Bryan, D., Sexton, C. J., Williams, D., Leigh, I. M., and McKay, I. A. Oral keratinocytes immortalized with the early region of human papillomavirus type 16 show elevated expression of interleukin 6, which acts as an autocrine growth factor for the derived T103C cell line. Cell Growth Differ., 6: 1245-1250, 1995.
35. Malejczyk, J., Malejczyk, M., Urbanski, A., Kock, A., Jablonsk, A. S., Orth, G., and Luger, T. A. Constitutive release of IL-6 by human papillomavirus type 16 (HPV 16) harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells. Cell. Immunol., 136: 155-164, 1991.
36. Wu T. C. Immunology of human papillomavirus in relation to cancer. Curr. Biol., 6: 746-754, 1994.
37. Li, S. L., Kim, M. S., Cherrick, H. M., Doniger, J., and Park, N-H. Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens. Carcinogenesis (Lond.), 13: 1981-1987, 1992.
38. Kyo, S., Inoue, M., Hayasaka, N., Inoue, T., Yatsudo, M., Tanizawa, O., and Hakura, A. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology, 200: 130-139, 1994.
39. Evans, C. H., Flugelman, A. A., and DiPaolo, J. A. Cytokine modulation of immune defenses in cervical cancer. Oncology, 50: 245-251, 1993.
40. Woodworth, C. D., and Simpson, S. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized and carcinoma cell lines. Am. J. Pathol., 142: 1544-1555, 1993.
41. Malejczyk, J., Malejczyk, M., Majewski, S., Breiburd, F., Lugar, T. A., Jablonska, S., and Orth, G. Increased tumorigenicity of human keratinocytes harboring human papillomavirus type 16 is associated with resistance to endogenous tumor necrosis factor-α mediated growth limitation. Int. J. Cancer, 56: 593-598, 1994.
42. Barten, M., Ostwald, C., Milde-Langosch, K., Muller, P., Wakasch, Y., and Loning, T. HPV DNA and p53 alteration in oropharyngeal carcinomas. Virchows Arch., 427: 153-157, 1995.
43. Gorgoulis, V., Rassidakis, G., Karameris, A., Giatromanolaki, A., Barvatis, C., and Kittas, C. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Arch., 425: 481-489, 1994.
44. Lewensohm-Fuchs, I., Manck-Wikland, E., Berke, Z., Magnusson, K. P., Pallesen, G., Auer, G., Lindholm, J., Linde, A., Aberg, B., Rubio, C., Kuylenstierna, R., Wiman, K. G., and Dalianis, T. Involvement of aberrant p53 expression and human papillomavirus in carcinoma of the head, neck and esophagus. Anticancer Res., 14: 1281-1285, 1994.
45. Santhanam, U., Grayeb, J., Schgal, P. B., and Nay, L. T. Repression of the IL-6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA, 88: 7605-7609, 1989.
46. Blay, J., Scheman, S., and Favrot, M. C. Local production of IL-6 by renal adenocarcinoma in vivo. J. Natl. Cancer Inst., 86: 238, 1994.
47. Eustace, D., Han, X., Gooding, R., Rowbottom, A., Riches, P., and Heyderman, E. Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Oncologic Oncol., 50: 15-19, 1993.
48. Siegall, C. B., Schwab, G., and Nordan, R. P. Expression of the interleukin-6 receptor and interleukin-6 in prostate cancer cells. Cancer Res., 50: 7786-7788, 1990, 1990.
49. Lotem, J., and Sachs, L. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc. Natl. Acad. Sci. USA, 93: 12507-12512, 1996.
50. Urshima, M., Ogata, A., Chauhan, D., Vidriales, M. B., Teoh, G., Hoshi, Y., Schlossman, R. L., DeCaprio, J. A., and Anderson, K. C. Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood, 8: 2219-2227, 1996.
51. Clayman, G. L., El-Naggar, A. K., Roth, J. A., Zhang, W-W., Goepfert, H., Taylor, D. L., and Liu, T-J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res., 55: 1-6, 1995.